M Schwenkglenks Selected Research

Melanoma (Melanoma, Malignant)

12/2015

A cost-effectiveness analysis of trametinib plus dabrafenib as first-line therapy for metastatic BRAF V600-mutated melanoma in the Swiss setting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Schwenkglenks Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 01/2017 - 03/2009
5	Neoplasms (Cancer) 01/2020 - 01/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 03/2011
3	Febrile Neutropenia 03/2014 - 03/2009
2	Neutropenia 03/2014 - 12/2011
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2011 - 01/2009
2	Lymphoma (Lymphomas) 12/2011 - 05/2008
1	Myocardial Infarction 10/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2018
1	Death (Near-Death Experience) 07/2017
1	Melanoma (Melanoma, Malignant) 12/2015
1	Ovarian Neoplasms (Ovarian Cancer) 03/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2014
1	Osteoporotic Fractures 03/2012
1	Lung Neoplasms (Lung Cancer) 03/2011
1	Anemia 01/2011
1	Fever (Fevers) 01/2009
1	Deglutition Disorders (Dysphagia) 01/2009
1	Multiple Myeloma 01/2009
1	Pain (Aches) 01/2009
1	Infections 01/2009
1	Stomatitis 01/2009
1	Osteoporosis 11/2007
1	Metabolic Bone Diseases (Osteopenia) 11/2007
1	Heart Failure 12/2000

Drug/Important Bio-Agent (IBA)

2	palbociclibIBA 01/2017 - 01/2016
2	Letrozole (Femara)FDA LinkGeneric 01/2017 - 01/2016
2	pegfilgrastim (Neulasta)FDA Link 12/2011 - 03/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2021
1	B7-H1 AntigenIBA 01/2020
1	durvalumabIBA 01/2020
1	NivolumabIBA 12/2018
1	Indicators and Reagents (Reagents)IBA 07/2017
1	trametinibIBA 12/2015
1	VemurafenibIBA 12/2015
1	dabrafenibIBA 12/2015
1	Docetaxel (Taxotere)FDA Link 10/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2014
1	Fluorouracil (Carac)FDA LinkGeneric 10/2014
1	Epirubicin (Ellence)FDA LinkGeneric 10/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 03/2014
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 03/2014
1	Cetuximab (Erbitux)FDA Link 03/2011
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2011
1	Cisplatin (Platino)FDA LinkGeneric 03/2011
1	IronIBA 01/2011
1	HematinicsIBA 01/2011
1	Trastuzumab (Herceptin)FDA Link 11/2010
1	Capecitabine (Xeloda)FDA Link 11/2010
1	Melphalan (Alkeran)FDA LinkGeneric 01/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2009
1	Opioid Analgesics (Opioids)IBA 01/2009
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2007
1	Bisoprolol (Concor)FDA LinkGeneric 12/2000

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 03/2014 - 05/2008
5	Therapeutics 07/2017 - 12/2000
1	Secondary Prevention 10/2021
1	Minor Surgical Procedures (Minor Surgery) 10/2021
1	Chemoradiotherapy 01/2020
1	Immunotherapy 01/2020
1	Complementary Therapies (Alternative Medicine) 07/2017
1	Adjuvant Chemotherapy 10/2014
1	Length of Stay 03/2012
1	Total Parenteral Nutrition 01/2009